Evidence map›Paper›PMID 12197890›Full record

Trial reportClinical and experimental immunology2002

Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates.

R Riganò, S Ioppolo, E Ortona, P Margutti, E Profumo, M D Ali, B Di Vico, A Teggi, A Siracusano

Abstract readCase ReportsClinical TrialControlled Clinical Trial
In one paragraph

Trial report in Clinical and experimental immunology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Prevesical hydatid cyst: A case report.Clinical case reports · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Detection ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  7. Article
  8. Article
  9. The effects ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Article
  10. Article
  11. Review
  12. Ultrasound and Cystic Echinococcosis.Ultrasound international open · 2018
    Review
  13. Article
  14. Article
  15. Factors Influencing the Serological Response in Hepatic Echinococcus granulosus Infection.The American journal of tropical medicine and hygiene · 2016
    Article
  16. Article
  17. Review
  18. Long-term albendazole effectiveness for hepatic cystic echinococcosis.The American journal of tropical medicine and hygiene · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

R RiganòDepartment of Immunology, Istituto Superiore di Sanità, Rome, Italy.
S Ioppolo
E Ortona
P Margutti
E Profumo
M D Ali
B Di Vico
A Teggi
A Siracusano

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seeking better immunological markers indicating the long-term outcome of cystic echinococcosis (CE) after chemotherapy we studied 23 patients receiving albendazole, clinically followed for 8 years, and grouped ultrasonographically according to therapeutic outcome. Antibody responses against a partially purified fraction of hydatid fluid (HFF) and antigen B (AgB) were evaluated by indirect haemagglutination (IHA), ELISA and immunoblotting (IB). Although IHA titres varied over the course of treatment, differences in mean antibody titres to HFF between groups were significant only at 4 years (P = 0.031). IgG isotype expression remained unchanged during follow-up whereas IgE expression decreased in patients with cured or stable disease. AgB disclosed higher IgG4 expression (P < 10(-4); P = 0.025) and lower IgG1 expression than HFF (P < 10(-4); P = 0.022). IHA antibody titres were higher in patients with progressive than in those with cured or stable disease, even in those with the same cyst type. ELISA isotype profiles differed between groups, particularly for type CE 3, 4 and 5 cysts: higher serum IgG1 and IgG3, lower IgG4 and IgE in patients with cured or stable disease. Although combined serological testing provides scarce information on the long-term outcome of CE after chemotherapy it may be useful for reviewing in a retrospective study the outcome of a cyst and for assessing the host-parasite relationship.

Indexed as

AdultAgedAlbendazoleAnimalsAntibodies, HelminthAnticestodal AgentsBiomarkersCystsDisease ProgressionEchinococcosisEchinococcusEnzyme-Linked Immunosorbent AssayFemaleFollow-Up StudiesHemagglutination TestsHumansAlbendazoleAntibodies, HelminthAnticestodal AgentsBiomarkers

Identifiers

PMID12197890
PMCPMC1906476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.